StemCells Inc. (STEM) was a big mover last session with its shares rising roughly 11% on the day. The upside was owing to a coverage initiated on the company by research firm Cantor Fitzgerald, with a Buy rating. This development led to far more shares changing hands yesterday than in a normal session. The day’s move breaks the recent trend of the company as the stock is now trading above the volatile price range of $0.59 to $0.64 since April 24.
This biopharmaceutical company has witnessed 1 positive estimate revision in the last 30 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s rally can turn into more strength down the road.
StemCells currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
A stock worth considering in the biomedical industry is Actelion Ltd. (ALIOF) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment